Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.43
Delayed Data
As of 1:30pm ET
 +0.02 / +4.88%
Today’s Change
0.35
Today|||52-Week Range
1.04
-41.10%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.41
Today’s open0.43
Day’s range0.40 - 0.43
Volume86,534
Average volume (3 months)506,069
Market cap$37.0M
Dividend yield--
Data as of 1:30pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
HTGMHTG Molecular Diagno...-0.08-1.41%
OPGNOpGen Inc+0.08+2.97%
--Protea Biosciences G...0.000.00%
ABACAoxin Tianli Group I...+0.03+4.00%
Data as of 1:08pm ET, 08/31/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts

Partner Offers